Intravenous dexmedetomidine for cesarean section; randamized controlled trial

Intravenous dexmedetomidine for cesarean section; randamized controlled trial - DEX_CS_RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025489

Enrollment

Registered

2016-12-31

Start date

2016-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient undergoing cesarean section

Interventions

DEX6 microg/kg/hr at 10 minutes, and 0.4 microg/kg/hr normal saline

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)elective patients undergoing epidural and spinal anesthesia 2)Provided written informed consent to undergo the procedure.

Exclusion criteria

Exclusion criteria: 1)emergency 2)severe complication 3)intraoperative massive bleeding 4)refusal 5)obesity 6)a congenital disease has already known

Design outcomes

Primary

Measure	Time frame
7-point Likert-like verbal rating scale for assessment of patients satisfaction with intraoperative sedation analgesia	—

Secondary

Measure	Time frame
QoR-40 nausea and vomiting effective time for spinal anesthesia	—

Countries

Japan

Contacts

Public ContactManabu Yoshimura

Japan Community Healthcare Organization Tokuyama Central Hospital Department of Anesthesiology

manabu-ygc@umin.ac.jp0834-28-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026